全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Inflammatory Myofibroblastic Tumor: A Rare Tumor in the Tongue

DOI: 10.1155/2013/787824

Full-Text   Cite this paper   Add to My Lib

Abstract:

Inflammatory myofibroblastic tumor is composed of myofibroblast and inflammatory cell infiltration of the tissue. Malign transformation and recurrence rate of this tumor is rare and accepted as benign fibroinflammatory disease. The main etiology is unclear, but infection, trauma, and immunologic event are accused. In this study, we presented a 75-year-old man with a mass on his tongue, which was diagnosed as “inflammatory myofibroblastic tumor.” This type of tumor is rarely seen in the tongue and might be difficult to diagnose. Complete mass excision was provided for an adaquete treatment. 1. Introduction Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor [1]. The etiology of IMT is contentious, also the nature of this tumor type (benign or malign) is still controversial [1–3]. But, because of its rarity, the current conception is altered from a benign reactive process to an intermediate neoplasm [4]. Different terms such as; inflammatory pseudotumor, histiocytoma, plasma cell histiocytoma complex, plasma cell granuloma, fibrohistiocytoma, xanthomatous granuloma, myxoid hamartoma, xanthomatous pseudotumor, spindle cell pseudotumor, inflammatory fibrosarcoma, benign myofibroblastoma, and inflammatory myofibroblastic proliferation were used for defining this tumor. World Health Organization (WHO) had consolidated this term as IMT in 1994 and declared it as a diagnostic classification for intermediate soft-tissue myofibroblastic neoplasm according to its well reproducible histological morphology [4, 5]. The tumor reported in the lung originally, but extra-pulmonary form, has been described in different organs and anatomic sites [6, 7]. Regardless of the site of origin, it is a circumscribed mass-forming process, composed of myofibroblasts, fibroblasts, histiocytes, and plasma cells. Although stromal fibrosis is a finding that is usually seen, tumor tends to be limited in the focal area [6, 8]. IMT is preferentially occurring in children and young adults [6]. In this report, we presented a 75-year-old male patient with inflammatory myofibroblastic tumor of the tongue presenting with pediculated large mass. 2. ??Case Report A 75-year-old man was referred to our clinic with a painless, pediculated large mass on the left side of the tongue. The lesion grew rapidly within four months. Oral examination revealed an approximately 4 centimeter (cm) in diameter, hard, partially ulcerated, and pediculated large mass on the left side of the tongue (Figure 1). There was no regional lymphadenopathy, and the remainder of physical examination was

References

[1]  S. T. Saab, J. L. Hornick, C. D. Fletcher, S. J. Olson, and C. M. Coffin, “IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link,” Modern Pathology, vol. 24, no. 4, pp. 606–612, 2011.
[2]  C. H. Lu, H. Y. Huang, H. K. Chen, J. H. Chuang, S. H. Ng, and S. F. Ko, “Huge pelvi-abdominal malignant inflammatory myofibroblastic tumor with rapid recurrence in a 14-year-old boy,” World Journal of Gastroenterology, vol. 16, no. 21, pp. 2698–2701, 2010.
[3]  Z. Song, Y. Zhang, X. Xu et al., “Inflammatory myofibroblastic tumor invading pulmonary trunk with multiple mediastinal lymph node metastasis,” Annals of Thoracic Surgery, vol. 92, no. 1, article e15, 2011.
[4]  H. S. Ong, T. Ji, C. P. Zhang et al., “Head and neck inflammatory myofibroblastic tumor (IMT): evaluation of clinicopathologic and prognostic features,” Oral Oncology, vol. 48, pp. 141–148, 2012.
[5]  J. M. Coindre, “Histologic classification of soft tissue tumors (WHO, 1994),” Annales de Pathologie, vol. 14, no. 6, pp. 426–427, 1994.
[6]  C. M. Coffin, P. A. Humphrey, and L. P. Dehner, “Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey,” Seminars in Diagnostic Pathology, vol. 15, no. 2, pp. 85–101, 1998.
[7]  M. Amin, R. Ali, S. Kennedy, and C. Timon, “Inflammatory myofibroblastic tumor of the nose and paranasal sinuses masquerading as a malignancy,” Ear, Nose & Throat Journal, vol. 91, pp. e1–e3, 2012.
[8]  S. Ramachandra, K. Hollowood, M. Bisceglia, and C. D. M. Fletcher, “Inflammatory pseudotumour of soft tissues: a clinicopathological and immunohistochemical analysis of 18 cases,” Histopathology, vol. 27, no. 4, pp. 313–323, 1995.
[9]  H. Graefe, F. Stellmacher, K. Sotlar, B. Wollenberg, and E. Gehrking, “Inflammatory pseudotumor of the hypopharynx: clinical diagnosis, immunohistochemical findings and treatment of this rare disease,” In Vivo, vol. 22, no. 6, pp. 817–820, 2008.
[10]  C. M. Coffin, J. L. Hornick, and C. D. M. Fletcher, “Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases,” American Journal of Surgical Pathology, vol. 31, no. 4, pp. 509–520, 2007.
[11]  A. Gleizal, C. Ranchere-Vince, and J. L. Beziat, “Inflammatory myofibroblastic tumour of the tongue: a case report,” British Journal of Oral and Maxillofacial Surgery, vol. 45, no. 5, pp. 423–424, 2007.
[12]  D. A. Arber, O. W. Kamel, M. van de Rijn et al., “Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor,” Human Pathology, vol. 26, no. 10, pp. 1093–1098, 1995.
[13]  R. Husak, B. Tebbe, S. Goerdt et al., “Pseudotumour of the tongue caused by herpes simplex virus type 2 in an HIV-1 infected immunosuppressed patient,” British Journal of Dermatology, vol. 139, no. 1, pp. 118–121, 1998.
[14]  C. Pankaj and C. Uma, “How to manage oral inflammatory myofibroblastic tumor (inflammatory pseudotumor)?” Oral Diseases, vol. 7, no. 5, pp. 315–316, 2001.
[15]  L. I. Goldblatt and D. L. Ellis, “Salivary gland tumors of the tongue: analysis of 55 new cases ansd review of the literature,” Cancer, vol. 60, no. 1, pp. 74–81, 1987.
[16]  M. Sands, J. Pepe, and R. B. Brown, “Tongue abscess: case report and review,” Clinical Infectious Diseases, vol. 16, no. 1, pp. 133–135, 1993.
[17]  T. Mentzel, S. Dry, D. Katenkamp, and C. D. M. Fletcher, “Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors,” American Journal of Surgical Pathology, vol. 22, no. 10, pp. 1228–1238, 1998.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133